The Hologic Global Access Initiative was launched at the International AIDS Society Conference in July 2018, setting a new standard for affordable and transparent pricing. The breakthrough agreement sets out one low price per-patient test including the costs of delivery, maintenance, and service as well as all consumables.
Under the agreement, MedAccess will underwrite the risk of supplying the tests in uncertain markets, allowing Hologic to introduce viral load testing to national government testing programmes at a significantly reduced rate. It is anticipated that the agreement will save public sector purchasers over $50m over the next four years and beyond. At least five countries in sub-Saharan Africa are expected to introduce this technology in 2018.
Read: CDC GROUP’S ARTICLE
Rt Hon Alistair Burt, Minister of State at DFID said:
Gavi, MedAccess and GlaxoSmithKline join forces to guarantee continued production of the RTS,S antigen for the RTS,S/AS01e malaria vaccine ahead of key policy and funding decisions.
MedAccess CEO Michael Anderson joined Laura Frigenti and Simba Makoni to discuss trends in financing for global health and how the COVID-19 pandemic has affected funding.
Extension will support UNICEF's work to accelerate access to essential supplies for countries around the world